StonvexLoading…
StonvexStonvexStonvexCore line items from PRKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $278.29M | $1.66B | $1.29B | $777.16M |
Operating Income | $-8.49M | $365.44M | $309.03M | $157.35M |
Net Income | $-34.07M | $168.35M | $153.30M | $80.11M |
EPS (Diluted) | $-0.69 | $3.06 | $2.76 | $1.15 |
Total Assets | $2.61B | $2.62B | $2.74B | $2.73B |
Total Liabilities | $3.16B | $3.05B | $3.05B | $3.13B |
Cash & Equivalents | $28.94M | $99.76M | $183.23M | $193.92M |
Free Cash Flow OCF − CapEx | $-2.83M | $162.60M | $134.46M | $96.45M |
Shares Outstanding | 49.42M | 54.99M | 55.45M | 55.44M |